Search Tag: AOP Health
2025 27 May
RHEACELL and AOP Health have formed a new strategic partnership to deliver breakthrough therapies for the "butterfly children's" disease and chronic venous wounds. This partnership aims to provide patients with high unmet medical needs access to innovative cell therapies. RHEACELL, a German biotech company specialised in the development of...Read more
2025 06 May
Out of Stock, Limited Options: How Drug Shortages Threaten Rare Disease Patients Imagine living with a chronic, rare disease, and that your health depends on a specific medication. Then, one day, it turns out to be unavailable. You do not know when it might be on-stock again, there are only limited alternatives, and the future looks uncertain. Many...Read more
2024 28 Nov
Vasopressin timing, patient selection, optimal vasopressin use in septic shock, and potential mortality benefits in selected patient populations. Septic Shock Overview and Current Treatments Septic shock is a severe, life-threatening response to infection, characterised by systemic inflammation, tissue hypoperfusion, and persistent,...Read more
2024 18 Nov
PH Awareness Month: survey results generated strong interest at European Respiratory Society (ERS) Congress PHA Europe presented the results of a patient survey 1 conducted in cooperation with AOP Orphan Pharmaceuticals GmbH (AOP Health) and OrphaCare in a poster presentation at the annual ERS congress in Vienna in September. The survey investigated...Read more
2024 06 Aug
A new therapeutic approach to fight cancer With the approval of its Phase-1 clinical trial SERONCO-1, AOP Health has reached another milestone in its growth story. To mark the start of the trial at Vall d’Hebron University Hospital in Barcelona AOP Health hosted a panel discussion in collaboration with the daily Austrian newspaper “Der Standard”...Read more
2024 20 Feb
Individualized therapies and the integration of the patient's perspective are becoming increasingly important. February 29 is Rare Disease Day. On this occasion, the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) takes a look at the challenges faced by patients with rare diseases and highlights the trends...Read more